Skip to main content
Caplight Logo









NÖK Therapeutics, Inc.

NÖK Therapeutics, Inc.

Private
Ormond Beach, FloridaHealthcare & Life Scienceshttps://www.noktx.com/

Last Round

Crowdfunding

Mar 26, 2026

Total Funding Raised

$524,500

Company Overview

NÖK Therapeutics, Inc. is a biotechnology company that develops autologous natural killer (NK) cell-based cancer therapies designed to be administered without lymphodepleting chemotherapy.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Precision Medicine, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

natural killer cell therapyNK cell therapyautologous cell therapyimmunotherapycancer immunotherapyhematological malignanciessolid tumorsevencalucelclinical-stage biotechcell therapynext-gen immunotherapyoff-the-shelf cell therapyoncology biotech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

NÖK Therapeutics, Inc. Comparables

Compare NÖK Therapeutics, Inc. with similar companies based on industry and business-model similarity.

NÖK Therapeutics, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
NKGen Biotech, Inc.
74%
ImmunityBio
70%
Acepodia
66%

NÖK Therapeutics, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
CrowdfundingMar 26, 2026
Corporate FundingDec 23, 2024

NÖK Therapeutics, Inc. Investors

Notable investors and investment history

NÖK Therapeutics, Inc. investors
InvestorRounds
Hilton Family OfficeCorporate Funding, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 26, 2026

    Raised $1.4K in a crowdfunding round.

  • Dec 23, 2024

    $10M raised with J. Bradley Hilton leading.

NÖK Therapeutics, Inc. Filings

Explore SEC and related filing metadata, where available.

NÖK Therapeutics, Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about NÖK Therapeutics, Inc.'s valuation, stock price, and market status.

Is NÖK Therapeutics, Inc. a public or private company?

NÖK Therapeutics, Inc. is a private company.

What is the current stock price of NÖK Therapeutics, Inc.?

NÖK Therapeutics, Inc. is a private company with no public stock price. No recent secondary market data is available.

How much is NÖK Therapeutics, Inc. worth (valuation)?

Valuation information for NÖK Therapeutics, Inc. is not publicly available.

Can I buy NÖK Therapeutics, Inc. stock?

NÖK Therapeutics, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was NÖK Therapeutics, Inc.'s last funding round?

NÖK Therapeutics, Inc.'s most recent funding round was Crowdfunding on March 26, 2026.

Who are the main investors in NÖK Therapeutics, Inc.?

Key investors in NÖK Therapeutics, Inc. include Hilton Family Office.

Will NÖK Therapeutics, Inc. IPO soon?

No public IPO plans have been announced for NÖK Therapeutics, Inc..

How can I track NÖK Therapeutics, Inc. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor NÖK Therapeutics, Inc.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersOrmond Beach, Florida
Employee Range1
Year Founded2024
Last FundingMar 26, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?